© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > BAY-6672
<< Back to October
oral prostaglandin F receptor GCPR antagonist
to treat IPF, in vivo efficacy in fibrosis model
from ~3M cmpd cell-based HTS and opt.
J. Med. Chem., Oct. 22, 2020 issue
Bayer AG, Wuppertal, DE
BAY-6672 (Bayer oral in vivo prostaglandin F receptor GCPR antagonist)
Unlock this content with a Premium membership to read it now.